Technology|Oncology Information Management Systems (OIMS)| December 22, 2017

Next-generation OIS integrates with RayStation 7 treatment planning system to provide workflow and task management support for multidisciplinary cancer treatment

RaySearch Launches RayCare Oncology Information System

December 22, 2017 — RaySearch announced the first release of RayCare, a newoncology information system (OIS)designed to connect the different oncology disciplines, boosting efficiency and ensuring optimal use of resources.

The first product release, RayCare 1, provides workflow and task management support for thetreatment planningprocess and an integrated planning experience in combination with RayStation 7. Communication around the planning process is consolidated through the messaging and comment system built into task management.

为了实现任务的自动分配和移交,RayCare 1还支持每个患者的护理团队。内置的放射肿瘤图像归档和通信系统(PACS)与工作流管理系统完全集成,利用自动化成像工作流,患者人口统计数据可以自动与其他医院系统同步。除了工作流程和任务管理功能,RayCare 1和RayStation 7结合起来为IBA的质子系统和Accuray的TomoTherapy系统提供治疗计划、管理和交付支持。

在随后的发布中,RayCare将发展成为一个机器学习OIS,具有协调肿瘤任务的能力,支持围绕每个患者的需求组织的全面癌症护理。This goal reflects the fact that many cancer patients receive a combination of treatment types, driving the need for combined workflows forradiation therapy, chemotherapy and surgery.

For more information:www.raysearchlabs.com

Related Content

RaySearch Releases RayStation 7 Radiotherapy Treatment Planning System

Oncology Information Systems Need to Integrate

Related Content

Research has potential to address significant unmet need, identify biomarkers that determine response to treatment
News|Lung Imaging

August 10, 2022 — Mount Sinai is leading a team of lung cancer researchers that has been awarded a three-year, $500,000 ...

TimeAugust 10, 2022
arrow
The U.S. Food and Drug Administration approved Enhertu (fam-trastuzumab-deruxtecan-nxki), an IV infusion for the treatment of patients with unresectable (unable to be removed) or metastatic (spread to other parts of the body) HER2-low breast cancer.
News|2022世界杯篮球预选赛赛程

August 8, 2022 — The U.S. Food and Drug Administration approved Enhertu (fam-trastuzumab-deruxtecan-nxki), an IV ...

TimeAugust 08, 2022
arrow
Dr. Milena Cavic, Institute for Oncology and Radiology of Serbia
News|Lung Imaging

August 8, 2022 — Representatives from the Diagnostics Working Group of the IASLC Early Detection and Screening Committee ...

TimeAugust 08, 2022
arrow
David Gerber, MD
News|Lung Imaging

August 8, 2022 — A clinical trial is only as powerful as its participants. For years, researchers have struggled to fill ...

TimeAugust 08, 2022
arrow
Under this collaboration, IBA will equip the proton therapy system and the proton gantry treatment room at the Fred Hutchinson Cancer Center with ConformalFLASH research functionality, which will enable preclinical research on FLASH therapy.
News|Proton Therapy

August 5, 2022 — IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology, Fred ...

TimeAugust 05, 2022
arrow
The oncology information systems market is projected to be worth $2.59 Bn by 2022 and is expected to grow to $5.4 Bn by 2032, at a CAGR of 7.8% from 2022 to 2032.
Feature|Oncology Information Management Systems (OIMS)

August 2, 2022 — The oncology information systems market is projected to be worth $2.59 Bn by 2022 and is expected to ...

TimeAugust 02, 2022
arrow
House-passed Appropriations Bills Include Key Measures to Improve Nuclear Medicine Patient Safety
News|Nuclear Imaging

July 27, 2022 — Patients for Safer Nuclear Medicine, a coalition of 29 patient advocacy organizations representing ...

TimeJuly 27, 2022
arrow
RaySearch Laboratories AB (publ) announces the launch of RayStation 12A, the latest version of the company’s advanced treatment planning system
News|Radiation Oncology

July 25, 2022 — RaySearch Laboratories AB announces the launch of RayStation* 12A, the latest version of the company’s ...

TimeJuly 25, 2022
arrow
NorthStar will provide Clovis with its environmentally preferred, high purity non-carrier-added (n.c.a.) Ac-225
News|PET Imaging

July 20, 2022 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization ...

TimeJuly 20, 2022
arrow
NorthStar will provide Clovis with its environmentally preferred, high purity non-carrier-added (n.c.a.) Ac-225
News|Radiopharmaceuticals and Tracers

July 20, 2022 — -NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and ...

TimeJuly 20, 2022
arrow
Subscribe Now